CrossBridge Bio
ApprovedCrossBridge Bio is a biotechnology company focused on innovating ADC Therapeutics through stable dual-linker payload technology.
Founded
2014
Focus
AntibodiesBiologics
About
CrossBridge Bio is a biotechnology company focused on innovating ADC Therapeutics through stable dual-linker payload technology.
Funding History
1Series AUndisclosedUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2014
LocationCambridge, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile